4.7 Article

LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells

Related references

Note: Only part of the references are listed.
Review Oncology

Exploring the NK cell platform for cancer immunotherapy

Jacob A. Myers et al.

Summary: NK cells have innate potential to kill cancer cells, leading to the development of various NK cell-based therapies for cancer treatment. The main focus of NK cell therapy research is on optimizing sources of therapeutic NK cells and enhancing their cytotoxicity and persistence in the body.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses

Tania Love Aaes et al.

Summary: Modern cancer therapies often combine cytotoxic strategies with immune activation to stimulate an antitumor response. Studying the interaction between antitumor cytotoxic therapies, cancer cells, and the immune system requires appropriate experimental tumor models. In this review, the focus is on the immunostimulatory and immunosuppressive properties of cancer cell lines used in immunogenic cell death studies.

CELL DEATH AND DIFFERENTIATION (2021)

Article Oncology

Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer

Giulia Petroni et al.

Summary: Preclinical findings suggest that delivering radiotherapy before CDK4/6 inhibitors can achieve superior antineoplastic effects in breast cancer models, questioning the design of clinical trials administering CDK4/6 inhibitors before radiotherapy in women with ER+ breast cancer.

CLINICAL CANCER RESEARCH (2021)

Article Oncology

Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors

James Spicer et al.

Summary: The study demonstrated that local administration of LTX-315 in patients with advanced solid tumors was well-tolerated and safe, with evidence of changes in the tumor microenvironment and immune-mediated anticancer activity. Analysis showed that LTX-315 induced necrosis and CD8(+) T-cell infiltration within the tumor microenvironment, as well as significant expansion of T-cell clones in peripheral blood.

CLINICAL CANCER RESEARCH (2021)

Review Biochemistry & Molecular Biology

Intratumoral heterogeneity in cancer progression and response to immunotherapy

Ilio Vitale et al.

Summary: Tumors evolve under various pressures and exhibit considerable heterogeneity in genetic, phenotypic, and behavioral aspects. This intratumoral heterogeneity influences disease progression and treatment sensitivity, necessitating consideration of multiple levels of heterogeneity in future therapeutic approaches.

NATURE MEDICINE (2021)

Review Immunology

Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer

Johanna Bodder et al.

Summary: Immunotherapeutic approaches have revolutionized the treatment of diseases like cancer, with a focus on modulating anti-tumor immune responses. Natural killer (NK) cells and dendritic cells (DCs) play crucial roles in cancer immunotherapy, and their bidirectional cross-talk within the tumor microenvironment is essential for treatment success.

FRONTIERS IN IMMUNOLOGY (2021)

Editorial Material Immunology

NK cell memory: discovery of a mystery

Ulrich H. von Andrian

NATURE IMMUNOLOGY (2021)

Review Oncology

Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides

Ilio Vitale et al.

Summary: The high heterogeneity among malignant cells poses a significant obstacle to the success of cancer therapy, calling for the development of approaches that can operate despite such intratumoral heterogeneity. Oncolytic peptides, with their ability to induce immunogenic cell death and robust anticancer immune responses independently of intratumoral heterogeneity, show promise as therapeutic tools.

TRENDS IN CANCER (2021)

Review Oncology

Oncolysis without viruses - inducing systemic anticancer immune responses with local therapies

Oliver Kepp et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Review Immunology

Immunological impact of cell death signaling driven by radiation on the tumor microenvironment

Maria Esperanza Rodriguez-Ruiz et al.

NATURE IMMUNOLOGY (2020)

Article Oncology

Radiotherapy Cooperates with IL15 to Induce Antitumor Immune Responses

Karsten A. Pilones et al.

CANCER IMMUNOLOGY RESEARCH (2020)

Article Multidisciplinary Sciences

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

Aitziber Buque et al.

NATURE COMMUNICATIONS (2020)

Article Hematology

Memory-like natural killer cells for cancer immunotherapy

Margery Gang et al.

SEMINARS IN HEMATOLOGY (2020)

Editorial Material Oncology

The NKG2A immune checkpoint - a new direction in cancer immunotherapy

Benjamin C. Creelan et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Review Cell Biology

Cancer Immunosurveillance by T Cells

Samhita Rao et al.

BIOLOGY OF T CELLS - PT B (2019)

Review Immunology

The NLRP3 inflammasome: molecular activation and regulation to therapeutics

Karen V. Swanson et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Review Oncology

Breast Cancer Immunotherapy: Facts and Hopes

Leisha A. Emens

CLINICAL CANCER RESEARCH (2018)

Article Oncology

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery

Suzanne I. S. Mosely et al.

CANCER IMMUNOLOGY RESEARCH (2017)

Article Multidisciplinary Sciences

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity

Claire Vanpouille-Box et al.

NATURE COMMUNICATIONS (2017)

Article Biochemical Research Methods

Complex heatmaps reveal patterns and correlations in multidimensional genomic data

Zuguang Gu et al.

BIOINFORMATICS (2016)

Article Biochemistry & Molecular Biology

The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade

T. Yamazaki et al.

CELL DEATH AND DIFFERENTIATION (2016)

Article Cell Biology

The oncolytic peptide LTX-315 triggers immunogenic cell death

H. Zhou et al.

CELL DEATH & DISEASE (2016)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Article Biochemical Research Methods

STAR: ultrafast universal RNA-seq aligner

Alexander Dobin et al.

BIOINFORMATICS (2013)

Article Biotechnology & Applied Microbiology

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

Guangchuang Yu et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)